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Case report Candida glabrata endophthalmitis following 
penetrating keratoplasty in a patient with negative 
donor rim culture
Mohd Nor Muzaliha, Hussein Adil, Mohtar Ibrahim and Ismail Shatriah*
Abstract
Background: Candida glabrata endophthalmitis following keratoplasty is rare and almost always associated with 
positive donor rim culture.
Case presentation: A 63-year-old patient, diagnosed Fuch's endothelial dystrophy in both eyes underwent a 
penetrating keratoplasty in his right eye. He had multiple underlying medical problems, which included diabetes 
mellitus, hypertension, hypoadrenalism on oral dexamethasone and fatty liver secondary to hypertrigliseridemia. He 
developed multiple suture abscesses, corneal haziness, retrocorneal white plaques and a level of hypopyon two weeks 
after an uneventful penetrating keratoplasty in his right eye. Cultures of the donor button and the transport media 
culture were negative. Candida glabrata was isolated successfully from the aqueous and vitreous taps. He was treated 
with a combination of topical, intracameral, intravitreal and intravenous Amphotericin B. His final visual acuity 
remained poor due to the haziness of the corneal button.
Conclusion: Candida glabrata endophthalmitis following penetrating keratoplasty can occur in negative donor rim 
and transport media cultures. The growth of the organism is facilitated by the patient's immunocompromised status. 
Awareness by the ophthalmologists and appropriate choice of antibiotics are mandatory in this challenging condition.
Background
Candida glabrata is a very rare cause of endophthalmitis
following penetrating keratoplasty. We reviewed 12
reported cases of Candida glabrata endophthalmitis fol-
lowing penetrating keratoplasty with varying onset from
1978 to 2010, in which most of them had positive donor
rim culture.
We report on a case of Candida glabrata endophthalm-
itis following an uneventful penetrating keratoplasty in an
immunocompromised patient. Cultures of the donor rim
and transport media did not grow any microorganism.
The organism was successfully isolated from both, the
aqueous and vitreous taps. A prompt recognition and
appropriate management are essential in this condition.
Case presentation
A 63-year-old gentleman with Fuch's endothelial dystro-
phy in both eyes underwent a penetrating keratoplasty in
his right eye. He had multiple underlying medical prob-
lems, which included diabetes mellitus, hypertension,
fatty liver secondary to hypertrigliseridemia and hypoa-
drenalism. He had been on oral dexamethasone 5 mg
morning and 2.5 mg night dose since 3 years ago.
The donor cornea was harvested eleven hours post-
mortem from a 56-year-old gentleman who died from
peritonitis secondary to perforated appendicitis, with
underlying pulmonary hypertension, valvular heart dis-
ease and chronic obstructive pulmonary disease. Donor
tissue was stored for nine days at 4°C in Optisol-GS cul-
ture solution.
The pre-op visual acuity was 6/60 with no improve-
ment with pinhole in the right eye and hand movement
with good projection of light in the left eye. There was
evidence of bullous keratopathy and guttata at the
endothelial layer of cornea in both eyes. The right eye was
pseudophakic. There was a dense cataract in his left eye.
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The intraocular pressure was normal in both eyes. Pre-
operative B-scan ultrasonography confirmed an intact
retina with clear vitreous. Systemic evaluations included
full blood picture and chest x-ray did not reveal foci of
infection.
The penetrating keratoplasty was uneventful. On day
one postoperatively, his visual acuity was counting fingers
at 2 feet. There was a generalized epithelial defect over
the whole corneal button. The epithelium healed com-
pletely after ten days.
At two weeks postoperative period, he complained of
pain in the right eye and his visual acuity deteriorated to
hand movement. The conjunctiva was congested and the
corneal became hazy. There were multiple suture
abscesses with retrocorneal plaques and a level of
hypopyon (Figure 1). B-scan ultrasonography showed
evidence of vitreous abscesses and a flat retina (Figure 2).
There was no organism isolated from either the cul-
tures of donor corneal rim or transport medium. How-
ever, both the aqueous and vitreous taps grew Candida
glabrata. Conjunctiva swab from the fellow eye and blood
culture were negative.
He was treated with a combination of treatment, which
included topical Amphotericin B 0.15% hourly and 0.5
mg/kg/day of intravenous Amphotericin B daily for the
duration of six weeks. An intravitreal injection of 5 μg
Amphotericin B was given once while performing the
aqueous and vitreous taps. 5 μg of Amphotericin B was
injected intracamerally two weeks later. He was moni-
tored closely for signs of Amphotericin B toxicity.
He did not develop any toxic effect or serious complica-
tion during the therapy except for a minimal elevation of
liver enzymes. He showed an encouraging clinical
improvement, though his final visual acuity remained
poor due to the haziness of the corneal button.
Conclusions
Candida glabrata endophthalmitis following penetrating
k e r a t oplas t y is  ve ry ra r e  but  has devas ta t ing  e ff ects.  I t
typically occurs within the first and second week post
penetrating keratoplasty [1-4]. In contrast, there were
cases occurred as early as 10 hours post transplantation
or as late as 5 months post surgery [5-7]. Our patient
developed features of endophthalmitis at two weeks post
penetrating keratoplasty.
Candida glabrata, formerly known as Torulopsis
glabrata  is a non-dimorphic/haploid yeast that has
recently emerged as an important nosocomial pathogen
[8]. It can be found in normal healthy skin, respiratory,
genitourinary and gastrointestinal systems. It is a highly
opportunistic pathogen of the urogenital tract and the
blood stream.
The prevalence is high in HIV positive patients and the
elderly, other risk factors include prolonged hospitaliza-
tion and prior antibiotic use [8]. Infection with Candida
glabrata can be mucosal or systemic, and occurs more
commonly in an immunocompromised or a debilitated
host.
Table 1 summarizes 12 reported cases of Candida
glabrata  endophthalmitis in the literature from 1998-
2010. All of the cases had either positive cultures of donor
rim or transport medium [1-7,9-12]. Both negative donor
rim and transport medium cultures in postkeratoplasty
endophthalmitis caused by Candida glabrata has never
been reported previously. To the best of our knowledge,
this is the first reported case of Candida glabrata postk-
eratoplasty endophthalmitis with negative donor rim and
transport medium cultures.
Figure 1 Anterior segment photograph showing multiple suture 
abscesses and retrocorneal white plaques at the donor host inter-
face at 2 weeks postoperative period.
Figure 2 B-scan ultrasonography showing evidence of vitreous 
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Table 1: Comparison between previously reported cases of Candida glabrata endophthalmitis following penetrating 
keratoplasty
Author/Year Age/Gender Indication for PK Onset of 
endophthalmitis
Culture Treatment Side effects
Larsen PA et al, 
1978
76/Female Aphakic bullous 
keratopathy
48 days Positive (donor 
rim and fluid)
Topical and intravenous 
amphotericin B, oral and 
topical flucytosine
Renal 
toxicity; 
death
Cameron JA et al, 
1991
22/Male Keratoconus 7 days Positive (donor 
rim)
Intravitreal amphotericin B, 
subconjunctival miconazole, 
topical natamycin,oral 
flucytocine
Not stated
Antonios et al, 
1991
30/Male Cornea scar 11 days Positive (donor 
rim)
Not stated Not stated
Cameron JA et al, 
1998
46/Male Cornea scar 3 weeks Positive (donor 
rim)
Not stated Not stated
Chapman FM et al, 
1998
43/Male Keratoconus 4 days Positive (transport 
medium)
Topical,intracameral and 
subconjunctival 
amphotericin B
Nil
Garcia-Valenzuela 
E et al, 2005
85/Female Fuch's endothelial 
dystrophy, 
pseudophakia
5 months Positive (donor 
rim)
Oral fluconazole, intravitreal 
and intrastromal 
amphotericin B,
Not stated
Keyhani et al, 
2005
82/Female Pseudophakia 
corneal oedema
1st to 2nd week Positive (donor 
rim)
Not stated Not stated
Grueb M et al, 
2006
26/Male Keratoconus 10 hours Positive (transport 
medium)
Systemic fluconazole, 
Topical and intracameral 
amphotericin B
Nil
Al Assiri A et al, 
2006
69/Male Trachomatous 
scarring
5 months Positive (donor 
rim)
Topical and intracameral 
amphotericin B, systemic 
fluconazole
Not stated
Caldwell MC et al, 
2009
57/Male Post LASIK 
keratectasia
10 days Positive (donor 
rim)
Oral fluconazole, intravitreal 
and topical amphotericin B, 
topical and oral voriconazole
Liver toxicity
Tappeiner C et al, 
2009
70/Female Fuch's endothelial 
dystrophy
1 day Positive (donor 
rim)
Oral fluconazole, topical and 
subconjunctival 
amphotericin B, intravenous 
liposomal amphotericin B 
and intravenous 
caspofungin
Not stated
Tappeiner C et al, 
2009
53/not 
stated
Fuch's endothelial 
dystrophy
1 day Positive (donor 
rim)
Oral fluconazole and 
voriconazole; intracameral 
and subconjunctival 
Amphotericin B, intravenous 
liposomal amphotericin B 
and intravenous 
caspofungin
Renal 
toxicity
Current study 63/Male Fuch's endothelial 
dystrophy
2 weeks Negative (donor 
rim and transport 
medium) Positive 
(recipient AC and 
vitreous tap 
culture)
Topical, intravenous, 
intravitreal and intracameral 
amphotericin B
NilMuzaliha et al. BMC Ophthalmology 2010, 10:18
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Cultures of the donor rim and transport medium were
negative in our patient. However, the organism was iso-
lated successfully from the aqueous and vitreous cultures.
It seems most likely that an unrecognized Candida
glabrata infection was present in the affected eye of the
recipient. It is less likely that the contamination occurred
during keratoplasty as it was performed under strictly
sterile condition. We believe that the patient's immuno-
compromised status facilitated the infection process.
Candida glabrata is resistant to fluconazole and the
other azoles group of antifungal but sensitive to Amphot-
ericin B [8]. Several mechanisms of azole resistance have
been identified, that include increased P-450-dependent
ergosterol and an energy-dependent efflux pump of flu-
conazole, possibly via a multidrug resistance-type trans-
porter [13,14]. Secondary in vitro resistance is the most
common form of resistance in candida glabrata [15]. The
reason for this rapid development of secondary antifun-
gal resistance is unknown, but the haploid state of can-
dida glabrata is thought to be a contributing factor [8].
In contrast, in vitro resistance of candida glabrata and
candida albicans to ketoconazole and itraconazole
accounts for only 15% but yet still significant [8]. Flucyto-
sine resistance has been described extensively in candida
albicans  but not in candida glabrata. It has not been
widely used in candida glabrata infections but may be
useful in the future.
Fortunately, clinically significant amphotericin B resis-
tance is still very uncommon among most Candida spe-
cies and amphotericin B resistance has not been
described in candida glabrata. In general, intracameral,
intravitreal, intrastromal, subconjunctival, topical and
systemic Amphotericin B have been used in the treat-
ment of the Candida glabrata endophthalmitis [1,4-
7,9,10,12].
Two patients developed renal toxicity after the treat-
ment with intravenous Amphotericin, one of them subse-
quently died [10,12]. Liver toxicity had been reported in a
patient who was treated concurrently with oral flucon-
azole [4]. Beside the above mentioned side effects, there
were no documented serious complications in Candida
glabrata  endophthalmitis patients treated with various
methods of Amphotericin B delivery (Table 1).
Fortunately, our patient did not develop any side effect
during the course of Amphotericin B treatment. We had
monitored him closely soon after commencing the treat-
ment. We did not encounter retinal toxicity being
reported as a side effect in our literature review though it
has been mentioned in rabbit eyes [16,17].
Beside drugs resistance, relapse of Candida glabrata
endophthalmitis is another challenging episode among
the managing ophthalmologists. It had been reported
months to years after primary eradication of the infection
[4,6,18]. Thus, it is very essential to monitor closely these
patients as the recurrence is common.
In conclusion, Candida glabrata endophthalmitis is
uncommon but a potentially devastating complication
following penetrating keratoplasty. A complete work-up
is essential to identify the source of infection and prompt
treatment is indicated. This case highlights that ophthal-
mologists should have a high index of suspicious espe-
cially when managing patients with
immunocompromised status even with negative donor
and transport media cultures.
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